Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?

Frank G. Schaap*, Peter L. M. Jansen, Steven W. M. Olde Damink

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)782-784
Number of pages3
JournalHepatology
Volume67
Issue number2
DOIs
Publication statusPublished - Feb 2018

Keywords

  • FATTY LIVER-DISEASE
  • HEPATOCELLULAR-CARCINOMA
  • HEPATOCARCINOGENESIS

Cite this